The Patent Finder

Method for Determining Drug-Sensitive Human Cell Lines by Analysis Method in Which Measurement of Activity of Two Types of Protein Kinase Is Used

Nitto Boseki Co., Ltd.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 2 of these applications claim priority to application PCT/JP2016/080544, filed Oct 14, 2016. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 10,724,071Method for Determining Drug-Sensitive Human Cell Lines by Analysis Method in Which Measurement of Activity of Two Types of Protein Kinase Is Used
In force
 · High confidence
Nitto Boseki Co., Ltd.In force
High confidence
US 10,995,359Method for Determining Drug-Sensitive Human Cell Lines by Analysis Method in Which Measurement of Activity of Two Types of Protein Kinase Is Used
In force
 · High confidence
Nitto Boseki Co., Ltd.In force
High confidence
US 11,372,001Anti-Human IGG4 Monoclonal Antibody and Methods of Making and Using Same
In force
 · High confidence
Nitto Boseki Co., Ltd.In force
High confidence
3 of 3 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited